Nuzenio

Free Survival The

Free Survival The news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Perioperative toripalimab improves event-free survival in non-small cell lung cancer - 2 Minute Medicine2 Minute Medicine · Sun, 09 Aug 2026 10:05:36 GMTTrastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMTLong-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLiveOncLive · Thu, 06 Aug 2026 12:18:02 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTTafinlar Plus Mekinist Triples Progression-Free Survival in Thyroid Cancer - Cure TodayCure Today · Fri, 31 Jul 2026 17:38:16 GMTCombination therapy improves progression-free survival for patients with metastatic dMMR colorectal cancer - medicalxpress.commedicalxpress.com · Fri, 31 Jul 2026 02:20:02 GMTELEVATE Trial Shows Disease-Free Survival Benefit With Adjuvant Ensartinib in ALK-Positive NSCLC - The ASCO PostThe ASCO Post · Tue, 28 Jul 2026 14:29:40 GMT

Timeline

Sun, 09 Aug 2026 10:05:36 GMTPerioperative toripalimab improves event-free survival in non-small cell lung cancer - 2 Minute Medicine
Fri, 07 Aug 2026 14:42:22 GMTTrastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO Post
Thu, 06 Aug 2026 14:00:43 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO Post
Thu, 06 Aug 2026 12:18:02 GMTLong-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLive
Wed, 05 Aug 2026 09:32:35 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatch
Fri, 31 Jul 2026 17:38:16 GMTTafinlar Plus Mekinist Triples Progression-Free Survival in Thyroid Cancer - Cure Today

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Free Survival The.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.